Login

Financial Snapshot

Revenue
TTM
$76.86M
Gross Margin
TTM
55.29%
Net Income
TTM
-$39.84M
Current Assets
2022 Q4
Current Liabilities
2022 Q4
Current Ratio
2022 Q4
234.92%
Total Assets
2022 Q4
Total Liabilities
2022 Q4
Book Value
2022 Q4
$32.59M
Cash
2022 Q4
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$30.56M

Stock Price

Loading...
Market Cap: $475.49 Million

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Accelerate Diagnostics, Inc Accuray Inc Beyond Air Inc Apyx Medical Inc SeaSpine Holdings Corp Sensus Healthcare Inc Zomedica Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support